Open filter menu

Redesigned enterovirus and parechovirus real-time PCR reagents

Enterovirus and parechovirus real-time PCR reagents Redesigned for PCR efficiency and biplex compatibility Bothell, WA, November 7, 2023 — ELITechGroup MDx LLC (EGMDx) announced availability of their redesigned enterovirus and parechovirus analyte specific reagents* (ASR). The ASRs are designed to be used in the development of real-time PCR assays and…

Honoring ELITechGroup’s Legacy: The MGB Stabilizer Revolution

In the world of molecular diagnostics, we often encounter groundbreaking innovations that deserve a tribute. Today, we pay homage to a pivotal moment in history—the invention of the MGB stabilizer, i.e., Minor Groove Binder stabilizer, by ELITechGroup MDx LLC (formerly known as Epoch Biosciences) in 1995. This unsung hero has…

ELIVERSE: the video teaser   ElitechGroup Mdx is pleased to announce that ELIVERSE will be launched in Europe in 2024. With its introduction, ELITechGroup will have launched three molecular sample-to-result platforms in 8 years. Read the press release here.

ELITechGroup Molecular inaugurates its new headquarter in Turin

Turin, 22nd December 2022 – ELITechGroup has inaugurated its new headquarters in Turin, becoming one of the largest molecular biology hubs in Europe. The inauguration was held on Friday 16th December in the presence of institutional figures, collaborators, and employees. At the ribbon cutting, Michela Favaro – Deputy Mayor of…

ELITe InGenius™ nominated for Scientists’ Choice Awards®!

  ELITe InGenius™ nominated for Scientists’ Choice Awards! Each year the Scientists’ Choice Awards® celebrates the laboratory products and manufacturers that make a difference to the industry. SelectScience began the Scientists’ Choice Awards® in 2007 to enable scientists to voice their opinions on the best laboratory products. Scientists are then…

ELITechGroup receives CE mark

ITALY, Torino, December 9th, 2021. ELITechGroup announced today that its SARS-CoV-2 Extended ELITe MGB® Kit reliably differentiates the SARS-CoV-2 Omicron (B.1.1.529) variant from other variants of concern. The in-silico analysis was confirmed by testing patient samples positive for different SARS-CoV-2 variants including Omicron. ELITechGroup is pleased to offer the SARS-CoV-2…

Our new Molecular MDR/MTB multiplex assay

Een high performance based on our MGB® technology: – MTB complex: M.tuberculosis, M.africanum, M.bovis, M.canetti, M.microti, M.caprae. – MGB resistence: Rifampicine en Izoniazide. – Ultra sensitive: 6CFU/ml! – Ready to use monoreagent. In combination with our RT-PCR Sample-to-Result ELITe InGenius the most flexible solution for the diagnosis of Tuberculosis. “